HUMIRA® Dosing for Moderate to Severe Crohn's Disease
HUMIRA is used to reduce the signs and symptoms of moderate to severe Crohn’s disease
in adults who have not responded well to conventional treatments. HUMIRA is also
for these adults with moderate to severe Crohn’s disease who have lost response
to or are unable to tolerate infliximab.
Serious infections have happened in patients taking HUMIRA. These infections
include tuberculosis (TB) and infections caused by viruses, fungi, or bacteria that
have spread throughout the body. Some patients have died from these infections.
HUMIRA may increase the chance of getting lymphoma or other cancers.
HUMIRA can cause serious side effects including allergic reactions, hepatitis B
virus reactivation, nervous system problems, blood problems, heart failure, certain
immune reactions (including a lupus-like syndrome), and new or worsening psoriasis.
HUMIRA is a medicine given by injection under the skin.
One of the most common side effects with HUMIRA is injection site reactions such
as redness, rash, swelling, itching or bruising. These symptoms usually go away
within a few days.
Make sure you have been instructed by a healthcare provider how to inject HUMIRA
before you do it yourself. Your first injection should be given under the supervision
of a healthcare professional.
You can call your doctor or 1-800-4HUMIRA (448-6472) if you have questions about
giving yourself an injection.
Your first 4 weeks on HUMIRA
Starting Dose:
On day 1* you will take 4 (four 40 mg injections) doses of HUMIRA.
On day 15 you will take 2 (two 40 mg injections) doses of HUMIRA.
Continuing Dose:
On day 29 you will take 1 (one 40 mg injection) dose of HUMIRA.
After day 29 you will begin your regularly scheduled dose of one Pen every other
week.
This dosing regimen is only intended for treatment of Crohn's disease.
Complete injection instructions are found in Medication Guide that comes within the HUMIRA box.
For injection assistance, call one of our nurses at 1.800.4.HUMIRA.